EXPONENTIAL BIOTHERAPIES INC has a total of 23 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are DANIELL HENRY, EOS NEUROSCIENCE INC and PRECISION BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Foods | |
#7 | Cocoa and sweets |
# | Name | Total Patents |
---|---|---|
#1 | Carlton Richard M | 23 |
#2 | Merril Carl R | 16 |
#3 | Adhya Sankar L | 12 |
#4 | Adhya Sankar | 4 |
#5 | Galpin Jeffrey E | 4 |
#6 | Loessner Martin | 3 |
Publication | Filing date | Title |
---|---|---|
AU2004200450A1 | Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium | |
US2005175594A1 | Virulent phages to control Listeria monocytogenes in foodstuffs and in food processing plants | |
EP1519750A2 | Oxygenating agents for enhancing host responses to microbial infections | |
US2001043924A1 | Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system | |
WO0069269A1 | Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium | |
US5811093A | Bacteriophage genotypically modified to delay inactivations by the host defense system | |
AU2274695A | Antibacterial therapy with genotypically modified bacteriophage |